Bo Ge
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 2
- Oncology 6
- Peptidase Inhibition and Analysis 5
- Co-authors
- Li Zhou (2 shared papers)Li Gao (1 shared paper)Lu Wang (1 shared paper)Lin Shi (1 shared paper)Wei Yi (1 shared paper)Ye Yu (1 shared paper)Xing Zhang (1 shared paper)Jun Chen (1 shared paper)
- Journals
- Frontiers in Endocrinology (3 papers)Medicine (2 papers)BioFactors (2 papers)Alzheimer s & Dementia (1 paper)Frontiers in Aging Neuroscience (1 paper)
- Partner nations
- ChinaGermanySouth Sudan
In The Last Decade
Bo Ge
23 papers receiving 533 citations
Peers
Comparison fields: 5 of 86
- Biomaterials 84
- Cancer Research 84
- Biological Psychiatry 12
- Biochemistry 26
- Applied Microbiology and Biotechnology 8
Countries citing papers authored by Bo Ge
This map shows the geographic impact of Bo Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ge more than expected).
Fields of papers citing papers by Bo Ge
This network shows the impact of papers produced by Bo Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ge. The network helps show where Bo Ge may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Ge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 134 | |
| 2 | 2015 | 83 | |
| 3 | 2015 | 44 | |
| 4 | 2018 | 31 | |
| 5 | 2021 | 29 | |
| 6 | 2017 | 28 | |
| 7 | 2018 | 27 | |
| 8 | 2018 | 27 | |
| 9 | 2020 | 23 | |
| 10 | 2019 | 19 | |
| 11 | 2022 | 18 | |
| 12 | 2018 | 13 | |
| 13 | 2020 | 13 | |
| 14 | 2019 | 10 | |
| 15 | 2008 | 10 | |
| 16 | 2022 | 7 | |
| 17 | 2021 | 7 | |
| 18 | MiR-26a inhibits cell proliferation and induces apoptosis in human bladder cancer through regulating EZH2 bioactivity. | 2017 | 6 |
| 19 | 2022 | 3 | |
| 20 | 2024 | 2 |
About Bo Ge
Bo Ge is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Cellular and Molecular Neuroscience, having authored 26 papers that have together received 538 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), MicroRNA in disease regulation (4 papers), Neuropeptides and Animal Physiology (4 papers), Nanoplatforms for cancer theranostics (2 papers), Nerve injury and regeneration (2 papers), RNA modifications and cancer (2 papers), Pediatric Urology and Nephrology Studies (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Biomaterials (84 citations), Cancer Research (84 citations), Biological Psychiatry (12 citations), Biochemistry (26 citations) and Applied Microbiology and Biotechnology (8 citations). Bo Ge has collaborated with scholars based in China, Germany and South Sudan. Frequent co-authors include Li Zhou, Li Gao, Lu Wang, Lin Shi, Wei Yi, Ye Yu, Xing Zhang, Jun Chen, Jian Chen and Tianpeng Zheng. Their work appears in journals such as Frontiers in Endocrinology, Medicine, BioFactors, Alzheimer s & Dementia and Frontiers in Aging Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.